Stocks in play: Optimind Pharma Corp
Announces today its acquisition of MindSetting Institute, a leader in psychedelic enhanced therapy training and educational programming. The completion of this acquisition introduces a new market opportunity for Optimind which will generate new revenue streams and allows the Company to bring evidence-based training and education for healthcare professionals into the psychedelics. Optimind Pharma Corp shares C.OMND are trading unchanged at $0.07.
Read:
Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America
Fresher, Healthier Food Options Coming Soon to an Airplane Tray Near You
Airline Industry Wooing Back Customers with Enhanced, Healthier Menu Options
Vegetarian and Vegan Fliers Winning Important Battle Over In-Flight Menu Options
Mega Grocery Store Chains Listening to Customers’ Demands for Nutritious, Clean-Label Foods